Clinical trial
A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of…
NCT00317330 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00317330 |
|---|---|
| Title | A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis |
| Official title | A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Isoniazid, Pyrazinamide, Rifampin |
| Enrollment | 6,400 |
| Start date | Dec 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Apr 24, 2006 |
| Last update posted | Aug 27, 2010 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: